Loading clinical trials...

Single Injection of REGN475/SAR164877 in the Treatment of Chronic Pancreatitis Pain | Clinical Trials | Clareo Health

TERMINATEDPhase 2NCT01001923

Single Injection of REGN475/SAR164877 in the Treatment of Chronic Pancreatitis Pain

Primary objective was to demonstrate the activity of REGN475/SAR164877 in reducing the pain associated with chronic pancreatitis. Secondary objectives were: * to assess the safety and tolerability o...

Lead sponsor: Regeneron Pharmaceuticals•17 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Trial snapshot

StatusTERMINATED

PhasePHASE2

Enrollment15

Start dateDec 2009

Last updatedMay 27, 2013

Condition

Abdominal Pain Upper

Locations shown

Sanofi-Aventis Investigational Site Number 840024

Arcadia, California

Sanofi-Aventis Investigational Site Number 840011

Bell Gardens, California

Sanofi-Aventis Investigational Site Number 840003

Monterey, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 27, 2013Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions